Our study revealed that 23 KEGG pathways corresponding to miR‐101‐3p were enriched, from which the top five pathways in which target genes were enriched were (a) the adherens junction pathway (hsa04520: P = 8.53 × 10−4), (b) the leishmaniasis pathway (hsa05140: P = 8.53 × 10−4), (c) the prolactin signaling pathway (hsa04917: P = 8.53 × 10−4), (d) pathways in cancer (hsa05200: P = 0.002) and (e) the mitogen‐activated protein kinase (MAPK) signaling pathway (hsa04010: P = 0.004). The gene discussed is PRL; the disease is cancer.